Biocardia Inc (BCDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,499 | -6,925 | -3,501 | -11,907 | -8,879 |
| Depreciation Amortization | 64 | 43 | 22 | 82 | 61 |
| Accounts receivable | 86 | 86 | 48 | -54 | -153 |
| Other Working Capital | 209 | 417 | 562 | -214 | 132 |
| Other Operating Activity | 1,017 | 668 | 309 | 1,532 | 1,275 |
| Operating Cash Flow | $-8,123 | $-5,711 | $-2,560 | $-10,561 | $-7,564 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12 | -12 | -10 | -70 | -68 |
| Investing Cash Flow | $-12 | $-12 | $-10 | $-70 | $-68 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,042 | 2,665 | 244 | 5,540 | 1,658 |
| Other Financing Activity | -435 | 0 | -180 | -418 | -231 |
| Financing Cash Flow | $2,607 | $2,665 | $64 | $5,122 | $1,427 |
| Beginning Cash Position | 7,363 | 7,363 | 7,363 | 12,872 | 12,872 |
| End Cash Position | 1,835 | 4,305 | 4,857 | 7,363 | 6,667 |
| Net Cash Flow | $-5,528 | $-3,058 | $-2,506 | $-5,509 | $-6,205 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,123 | -5,711 | -2,560 | -10,561 | -7,564 |
| Capital Expenditure | -12 | -12 | -10 | -70 | -68 |
| Free Cash Flow | -8,135 | -5,723 | -2,570 | -10,631 | -7,632 |